DB:COP

Stock Analysis Report

CompuGroup Medical Societas Europaea

Executive Summary

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide.

Snowflake

Fundamentals

Proven track record average dividend payer.


Similar Companies

Share Price & News

How has CompuGroup Medical Societas Europaea's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

8.2%

COP

5.6%

DE Healthcare Services

4.4%

DE Market


1 Year Return

20.1%

COP

4.8%

DE Healthcare Services

1.6%

DE Market

Return vs Industry: COP exceeded the German Healthcare Services industry which returned 4.8% over the past year.

Return vs Market: COP exceeded the German Market which returned 1.6% over the past year.


Shareholder returns

COPIndustryMarket
7 Day8.2%5.6%4.4%
30 Day20.4%11.2%0.8%
90 Day-20.3%-19.8%2.3%
1 Year21.1%20.1%5.6%4.8%4.8%1.6%
3 Year45.7%42.2%44.8%40.3%18.9%8.6%
5 Year231.8%216.9%211.0%183.8%43.7%24.1%

Price Volatility Vs. Market

How volatile is CompuGroup Medical Societas Europaea's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is CompuGroup Medical Societas Europaea undervalued compared to its fair value and its price relative to the market?

33.93x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Undervalued: COP (€57.05) is trading above our estimate of fair value (€35.79)

Significantly Undervalued: COP is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: COP is poor value based on its PE Ratio (33.9x) compared to the Healthcare Services industry average (11.2x).

PE vs Market: COP is poor value based on its PE Ratio (33.9x) compared to the German market (19.5x).


Price to Earnings Growth Ratio

Low PEG Ratio: COP is poor value based on its PEG Ratio (3.1x)


Price to Book Ratio

PB vs Industry: COP is overvalued based on its PB Ratio (10.9x) compared to the DE Healthcare Services industry average (2x).


Next Steps

Future Growth

How is CompuGroup Medical Societas Europaea forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

10.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: COP's forecast earnings growth (10.9% per year) is above the savings rate (0.2%).

Earnings vs Market: COP's earnings (10.9% per year) are forecast to grow slower than the German market (12.6% per year).

High Growth Earnings: COP's earnings are forecast to grow, but not significantly.

Revenue vs Market: COP's revenue (3.7% per year) is forecast to grow slower than the German market (5% per year).

High Growth Revenue: COP's revenue (3.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: COP's Return on Equity is forecast to be high in 3 years time (31%)


Next Steps

Past Performance

How has CompuGroup Medical Societas Europaea performed over the past 5 years?

22.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: COP's earnings have grown significantly by 22.5% per year over the past 5 years.

Accelerating Growth: COP's earnings growth over the past year (57%) exceeds its 5-year average (22.5% per year).

Earnings vs Industry: COP earnings growth over the past year (57%) exceeded the Healthcare Services industry 37.6%.


Return on Equity

High ROE: Whilst COP's Return on Equity (32.05%) is high, this metric is skewed due to their high level of debt.


Return on Assets

ROA vs Industry: COP's Return on Assets is below or equal to the Healthcare Services industry average last year.


Return on Capital Employed

ROCE Improving: COP has significantly improved its Return on Capital Employed over the past 3 years.


Next Steps

Financial Health

How is CompuGroup Medical Societas Europaea's financial position?


Financial Position Analysis

Short Term Liabilities: COP's short term assets (€216.3M) do not cover its short term liabilities (€241.0M)

Long Term Liabilities: COP's short term assets (216.3M) do not cover its long term liabilities (455.2M)


Debt to Equity History and Analysis

Debt Level: COP's debt to equity ratio (131.8%) is considered high

Reducing Debt: COP's debt to equity ratio has reduced from 185.8% to 131.8% over the past 5 years.

Debt Coverage: COP's debt is well covered by operating cash flow (50.2%).

Interest Coverage: COP's interest payments on its debt are well covered by EBIT (21.3x coverage).


Balance Sheet

Inventory Level: COP has a low level of unsold assets or inventory.

Debt Coverage by Assets: COP's debt is not covered by short term assets (assets are 0.6x debt).


Next Steps

Dividend

What is CompuGroup Medical Societas Europaea's current dividend yield, its reliability and sustainability?

0.88%

Current Dividend Yield


Dividend Yield vs Market

company0.9%marketbottom25%1.4%markettop25%3.8%industryaverage1.7%forecastin3Years1.0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: COP's dividend (0.88%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.45%).

High Dividend: COP's dividend (0.88%) is low compared to the top 25% of dividend payers in the German market (3.85%).

Stable Dividend: COP's dividends per share have been stable in the past 10 years.

Growing Dividend: COP's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (29.9%), COP's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: COP's dividends in 3 years are forecast to be well covered by earnings (20.5% payout ratio).


Next Steps

Management

What is the CEO of CompuGroup Medical Societas Europaea's salary, the management and board of directors tenure and is there insider trading?

1.8yrs

Average management tenure


CEO

Frank Gotthardt (69yo)

11.3yrs

Tenure

€4,193,700

Compensation

Mr. Frank Gotthardt has been the Chairman of Management Board and Chief Executive Officer of CompuGroup Medical Societas Europaea (formerly, CompuGroup Holding AG) since July 1, 2008. He has been Chairman  ...


CEO Compensation Analysis

Compensation vs. Market: Frank's total compensation ($USD4.64M) is about average for companies of similar size in the German market ($USD2.78M).

Compensation vs Earnings: Frank's compensation has increased by more than 20% in the past year.


Management Age and Tenure

1.8yrs

Average Tenure

51.5yo

Average Age

Experienced Management: COP's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Age and Tenure

3.7yrs

Average Tenure

Experienced Board: COP's board of directors are considered experienced (3.7 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Christian Teig (54yo)

    Executive Officer

    • Tenure: 0.2yrs
    • Compensation: €810.24k
  • Frank Gotthardt (69yo)

    Chairman of Management Board & CEO

    • Tenure: 11.3yrs
    • Compensation: €4.19m
  • Uwe Eibich (57yo)

    Member of Management Board

    • Tenure: 12.8yrs
    • Compensation: €640.56k
  • Ralph Körfgen

    Member of Executive Board

    • Tenure: 0.9yrs
    • Compensation: €453.05k
  • Hannes Reichl

    Member of Executive Board

    • Tenure: 0.9yrs
    • Compensation: €452.10k
  • Benedikt Brückle

    Senior Vice President of United States & Canada

    • Tenure: 2.8yrs
  • Oliver Bruzek

    Chief Communication Officer of Political & Public Affairs

    • Tenure: 0yrs
  • Frank Brecher (49yo)

    Chief Process Officer & Member of Management Board

    • Tenure: 4.5yrs
    • Compensation: €558.01k
  • Claudia Thomé (49yo)

    Head of Investor Relations

    • Tenure: 0yrs
  • Michael Rauch (46yo)

    CFO & Member of Management Board

    • Tenure: 0.2yrs

Board Members

  • Klaus Esser

    Chairman of Supervisory Board

    • Tenure: 5.4yrs
  • Thomas Seifert (56yo)

    Member of Supervisory Board

    • Tenure: 1.7yrs
  • Daniel Gotthardt

    Deputy Chairman of Supervisory Board

    • Tenure: 0yrs
  • Dierk Heimann

    Member of Medical Advisory Board

    • Tenure: 0yrs
  • Ulrike Handel

    Supervisory Board Member

    • Tenure: 2.4yrs
  • Maik Pagenkopf

    Employee Representative Supervisory Board Member

    • Tenure: 3.7yrs
  • Klaus Schrod

    Employee Representative Supervisory Board Member

    • Tenure: 3.7yrs

Company Information

CompuGroup Medical Societas Europaea's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CompuGroup Medical Societas Europaea
  • Ticker: COP
  • Exchange: DB
  • Founded: 1979
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: €2.754b
  • Shares outstanding: 48.57m
  • Website: https://www.cgm.com

Number of Employees


Location

  • CompuGroup Medical Societas Europaea
  • Maria Trost 21
  • Koblenz
  • Rhineland-Palatinate
  • 56070
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
COPDB (Deutsche Boerse AG)YesCommon SharesDEEURJul 1996
0MSDLSE (London Stock Exchange)YesCommon SharesGBEURJul 1996
CMPV.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJul 1996
COPXTRA (XETRA Trading Platform)YesCommon SharesDEEURJul 1996
COPDBATS-CHIXE (BATS 'Chi-X Europe')YesCommon SharesGBEURJul 1996
COPWBAG (Wiener Boerse AG)YesCommon SharesATEURJul 1996
COMPGSWX (SIX Swiss Exchange)YesCommon SharesCHCHFJul 1996
COP1 NBMV (Bolsa Mexicana de Valores)YesCommon SharesMXMXNJul 1996

Biography

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company’s Ambulatory Information Systems segment provides practice  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/16 20:41
End of Day Share Price2019/10/16 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.